News | Cath Lab | August 15, 2017

Safety-Net vs. Non-Safety-Net Hospitals Deliver Similar PCI Outcomes

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals.

Aug. 15, 2017 – Patients undergoing percutaneous coronary intervention (PCI) at safety-net hospitals experienced similar outcomes as patients treated at non-safety-net hospitals, according to research published Aug. 7 issue of JACC: Cardiovascular Interventions. Read the abstract.

Safety-net hospitals in the U.S. serve the nation’s most vulnerable patients, with a focus on providing quality care to patients who are low income and/or uninsured or underinsured, as well as to patients who have insurance. Notably, safety-net hospitals may have fewer resources than other hospitals. In this study, a safety-net hospital was defined as having a PCI volume of at least 10 percent for patients without insurance, based on the Agency of Healthcare Quality and Research definition.

“The patients treated at safety-net hospitals often have critical heart problems and other health issues that, in many cases, have not been adequately managed,” said senior study author John Ambrose, M.D., FACC, emeritus chief of cardiology at the University of California, San Francisco (USCF-Fresno) in Fresno, and professor of medicine at UCSF. “Therefore, the fact that these hospitals are able to keep mortality rates low and achieve these outcomes when performing PCI — nearly matching non-safety net hospitals—is quite remarkable.”

The investigators used data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) CathPCI Registry from 2009 to 2015. They analyzed data from 3,746,961 patients who underwent PCI at 282 safety-net hospitals and 1,134 non-safety-net hospitals. The results showed risk-adjusted in-hospital mortality was only marginally higher in the safety-net hospitals (at four additional patients per 1,000 cases of PCI) than in non-safety-net-hospitals. Patients who went to safety-net hospitals tended to be younger, had more risk factors and more often entered through the emergency department because of a heart attack.

The study also found that both types of hospitals had similar rates of risk-adjusted bleeding and acute kidney injury, which are adverse events associated with PCI procedures. The results of the study are limited to the events that occurred while in the hospital.

“Clinical care is often complex. Because of that, it can be hard to make comparisons to understand what type of care is contributing to a positive outcome and what isn’t,” Ambrose said. “However, with this study, we now know that the hospital itself was not a significant factor in determining how well a patient did after their PCI procedure. The similarities we found also suggested that we can use the current NCDR risk model as a foundation for future comparisons between safety-net and non-safety-net hospitals.”

In an accompanying editorial, Theodore A. Bass, M.D., said that in addition to being vulnerable, the patients studied frequently have little or no ability to select their access to health care institutions or medical providers based on quality outcomes. He added that the study is particularly timely because of the discussion about health care legislation that has the potential to substantially affect resources for safety-net hospitals.

For more information: JACC.org

 

Related ACC NCDR Data Studies:

Study Finds Significant Variability in Doctors' Angioplasty Death Rates

Radial Access, Same-Day Cardiac Procedure Could Save $300 Million Annually

New Report Highlights National Trends in Heart Disease Treatments

Better Prognosis for Some PCI Patients When Operators Perform More Procedures

Radial Access Adoption in the United States

 

Reference:

1. Tushar Acharya, Adam C. Salisbury, John A. Spertus, et al. “In-Hospital Outcomes of Percutaneous Coronary Intervention in America’s Safety Net, Insights From the NCDR Cath-PCI Registry.” JACC: Cardiovascular Interventions. Volume 10, Issue 15, August 2017 DOI: 10.1016/j.jcin.2017.05.042
 

 

 

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Overlay Init